Kyverna Therapeutics, Inc. (KYTX)
8.07
-0.11
(-1.34%)
USD |
NASDAQ |
Dec 11, 11:08
Kyverna Therapeutics Price: 8.07 for Dec. 11, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| CEL-SCI Corp. | 6.60 |
| AIM ImmunoTech, Inc. | 1.50 |
| IGC Pharma, Inc. | 0.3321 |
| NovaBay Pharmaceuticals, Inc. | 2.655 |
| Protalix Biotherapeutics, Inc. | 1.77 |
Price Related Metrics
| PEG Ratio | -0.1022 |
| Price to Book Value | 2.326 |
| Earnings Yield | -46.11% |
| Market Cap | 353.44M |
| PEGY Ratio | -0.1022 |